Desvenlafaxine
- Product NDC
- 68382-105
- 11-digit product format
- 683820105
- Labeler code
- 68382
- Product ID
- 68382-105_281d1f1b-df9d-4c11-86c3-df47e59fe8b0
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Desvenlafaxine
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Zydus Pharmaceuticals USA Inc.
- Application
- ANDA204020
- Marketing category
- ANDA
- Marketing start
- 2023-01-03
- Marketing end
- 0000-00-00
- Substance
- DESVENLAFAXINE
- Active strength
- 25 mg/1
- Pharmacologic classes
- Cytochrome P450 2D6 Inhibitors [MoA], Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2024-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 68382-105-06 | 68382010506 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (68382-105-06) | 2023-01-03 | 0000-00-00 | No | No | Current |
| 68382-105-16 | 68382010516 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (68382-105-16) | 2023-01-03 | 0000-00-00 | No | No | Current |